Removal of access to alemtuzumab for patients with aggressive multiple sclerosis
10:54 EST 18 Jan 2013 | British Medical Journal
Although some treatments are now available for multiple sclerosis, better treatments are needed for people with aggressive disease. The need to find agents that can prevent or slow disease...
Original Article: Removal of access to alemtuzumab for patients with aggressive multiple sclerosis
More From BioPortfolio on "Removal of access to alemtuzumab for patients with aggressive multiple sclerosis"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
